
Epipole
Founded Year
2011Stage
Private Equity - II | AliveTotal Raised
$3.63MLast Raised
$1.76M | 1 yr agoMissing: Epipole's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Epipole's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Epipole
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Epipole is included in 3 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,623 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Health IT
7,901 items
Epipole Patents
Epipole has filed 1 patent.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/24/2013 | 2/11/2020 | Abdomen, Ophthalmology, Disorders of choroid and retina, Diseases of the eye and adnexa, Polarization (waves) | Grant |
Application Date | 10/24/2013 |
---|---|
Grant Date | 2/11/2020 |
Title | |
Related Topics | Abdomen, Ophthalmology, Disorders of choroid and retina, Diseases of the eye and adnexa, Polarization (waves) |
Status | Grant |
Latest Epipole News
Dec 7, 2022
The Global Nonmydriatic Handheld Fundus Cameras Market size was estimated at USD 49.67 million in 2021 and expected to reach USD 55.63 million in 2022, and is projected to grow at a CAGR 12.23% to reach USD 99.32 million by 2027. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period. Market Segmentation & Coverage: This research report categorizes the Nonmydriatic Handheld Fundus Cameras to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Type, the market was studied across Image Acquisition System and Optical System. Based on Application, the market was studied across Fluorescein Angiography and Fundus Imaging. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Nonmydriatic Handheld Fundus Cameras market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nonmydriatic Handheld Fundus Cameras Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nonmydriatic Handheld Fundus Cameras Market, including Canon, Inc., Carl Zeiss Meditec AG, CenterVue SpA, Clarity Medical Systems, Inc., Epipole Ltd, Forus Health Pvt Ltd, Guardion Health Sciences, Inc., Huvitz Corp., Kody Medical Electronics Pvt Ltd., Kowa Company Ltd., MediWorks, NIDEK Co., Ltd., Optomed Oy Ltd., OPTOPOL Technology Sp. z o.o., Remidio Innovative Solutions Pvt Ltd., Robert Bosch GmbH, Shanghai Canton Optics Equipment Co., Ltd., Suzhou MicroClear Medical Instruments Co., Ltd, Topcon Corporation, Veatch Ophthalmic Instruments, and Visionix Ltd.. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Nonmydriatic Handheld Fundus Cameras Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nonmydriatic Handheld Fundus Cameras Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nonmydriatic Handheld Fundus Cameras Market? 4. What is the competitive strategic window for opportunities in the Global Nonmydriatic Handheld Fundus Cameras Market? 5. What are the technology trends and regulatory frameworks in the Global Nonmydriatic Handheld Fundus Cameras Market? 6. What is the market share of the leading vendors in the Global Nonmydriatic Handheld Fundus Cameras Market? 7. What modes and strategic moves are considered suitable for entering the Global Nonmydriatic Handheld Fundus Cameras Market?
Epipole Frequently Asked Questions (FAQ)
When was Epipole founded?
Epipole was founded in 2011.
Where is Epipole's headquarters?
Epipole's headquarters is located at Arrol House, Rosyth.
What is Epipole's latest funding round?
Epipole's latest funding round is Private Equity - II.
How much did Epipole raise?
Epipole raised a total of $3.63M.
Who are the investors of Epipole?
Investors of Epipole include Greenwood Way Capital, Scottish Enterprise and Scottish Investment Bank.
Who are Epipole's competitors?
Competitors of Epipole include RetInSight.
Compare Epipole to Competitors
Provider of retina and cornea imaging systems. The company provides products designed to prevent eye diseases in primary and secondary care, for screening and early diagnosis of diabetic retinopathy (DR), and other eye diseases such as age-related macular degeneration (AMD) and glaucoma.
Intelligent Retinal Imaging Systems (IRIS) develops a retinal telemedicine assessment service based on technology developed at the Florida Institute for Human and Machine Cognition. IRIS's technology is targeted at preventing two of the leading causes of blindness in adults: diabetic retinopathy and glaucoma. IRIS's systems were developed by retina specialty physicians to more efficiently diagnose the early stages of preventable eye disease, giving patients and physicians unprecedented access to drive quality outcomes and reduce the cost of care.

Retina Labs provides telehealth and virtual care solutions for eye care professionals. The cloud-based iVision teleophthalmology and live teleconsult platform streamlines the management of chronic eye diseases such as diabetic retinopathy, glaucoma, age related macular degeneration and retinopathy of prematurity. iVision provides eye care professionals a comprehensive solution that combines advanced ocular imaging, clinical interpretation and reporting tools with integrated Electronic Medical Records, Practice Management and electronic referrals.
Deepdee is working on machine diagnostics of eye diseases by processing photos of the eye fundus with AI/ML algorithms. Deepdee has access to a large database of retina scan images, which they aim to annotate quickly.
Phelcom Technologies is a developer of medical devices, including Phelcom Eyer, a portable retinal camera.

Retina Technologies is a medical device company that develops the OcuVue digital vision screening platform to help eliminate treatable vision loss and blindness by enabling early detection and prevention. It aims to end needless vision loss and blindness for everyone across the globe. It was founded in 2018 and is based in New York, New York.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.